ENDPOINTS

GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says

GSK said its decoupling with Haleon is a key reason why it views itself as “well-positioned” in the face of potential pharma-specific tariffs. When the drugmaker went through its “demerger” with the ...

Apr 30, 2025 - 12:23
 0
GSK's supply chain 'reset' after Haleon spinoff to ease tariff impact, CEO says
GSK said its decoupling with Haleon is a key reason why it views itself as “well-positioned” in the face of potential pharma-specific tariffs. When the drugmaker went through its “demerger” with the ...
Read More

Tags:

Previous Article

GSK's supply chain 'reset' after Haleon spinoff will ease tariff impact, CEO says

Next Article

Mixed Reality Cycling Game Legends BMX Launches Next Week

Related Posts

Biosimilar launch challenges remain, report finds

Biosimilar launch challenges remain, report finds

Apr 24, 2025  0

FDA delays decision date for small biotech, raising questions about impact of agency cuts

FDA delays decision date for small biotech, raising que...

Apr 29, 2025  0

China’s biotech market is staging a comeback that US biotech can only wish for

China’s biotech market is staging a comeback that US bi...

Apr 23, 2025  0